Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells

Article ID	Journal	Published Year	Pages	File Type
5558271	Toxicology and Applied Pharmacology	2017	12 Pages	PDF

Keywords

EGFR T790M Crm1 LMB TKIs MTT EMT KRAS mutation NSCLC Non-small cell lung cancer Leptomycin B Acquired resistance Tyrosine kinase inhibitors chromosome region maintenance 1 Epithelial-mesenchymal transition Epidermal growth factor receptor

Related Topics

Life Sciences Environmental Science Health, Toxicology and Mutagenesis

Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells

Authors

Zhongwei Liu, Weimin Gao,